Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania

Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, and the Bipolar Disorders Program, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Journal of psychiatry & neuroscience: JPN (Impact Factor: 7.49). 10/2006; 31(5):326-32.
Source: PubMed

ABSTRACT Previous studies have suggested that oxidative stress may play a role in the pathophysiology of bipolar disorder (BD). Moreover, recent studies indicate that lithium and valproate exert neuroprotective effects against oxidative stress. We studied the effects of the mood stabilizers lithium and valproate on amphetamine-induced oxidative stress in an animal model of mania.
In the first model (reversal treatment), adult male Wistar rats received d-amphetamine or saline for 14 days, and between the 8th and 14th days, they were treated with lithium, valproate or saline. In the second model (prevention treatment), rats were pretreated with lithium, valproate or saline, and between the 8th and 14th days, they received d-amphetamine or saline. We assessed locomotor activity with the open-field task. We measured thiobarbituric acid reactive substances (TBARS) and protein carbonyl formation, as parameters of oxidative stress, and superoxide dismutase (SOD) and catalase (CAT), the major antioxidant enzymes, in the prefrontal cortex and hippocampus.
Lithium and valproate reversed (reversal treatment model) and prevented (prevention treatment model) amphetamine-induced hyperactivity and reversed and prevented amphetamine-induced TBARS formation in both experiments. However, the co-administration of lithium or valproate with amphetamine increased lipid peroxidation, depending on the brain region and treatment regimen. No changes in protein carbonyl formation were observed. SOD activity varied with different treatment regimens, and CAT activity increased when the index of lipid peroxidation was more robust.
Our findings suggest that lithium and valproate exert protective effects against amphetamine-induced oxidative stress in vivo, further supporting the hypothesis that oxidative stress may be associated with the pathophysiology of BD.

Download full-text


Available from: Fabrícia Petronilho, May 23, 2014
  • Source
    • "We also measured the effect of social defeatinduced stress on oxidative stress within three critical brain areas, considered vital for depression, anxiety and cognition, namely, hippocampus, amygdala and prefrontal cortex (McEwen et al., 2012). Oxidative stress which is defined as the imbalance between production of reactive oxygen and nitrogen species (RONS) and their inefficient decomposition by the antioxidant system (Lau et al., 2011; Patki et al., 2009; Sies, 1997), has been implicated in the pathophysiology of depression, anxiety and other psychiatric disorders (Frey et al., 2006; Gibson et al., 2012; Kiecolt-Glaser et al., 2013; Maurer et al., 2001; Rezin et al., 2009). Actually, large consumption of oxygen, high amount of polyunsaturated fatty acids and iron content with diminished antioxidant enzymatic activity make brain a vulnerable target for oxidative stress (Evans, 1993) increasing its vulnerability to disease. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the present study, we have examined the behavioral and biochemical effect of induction of psychological stress using a modified version of the resident-intruder model for social stress (social defeat). At the end of the social defeat protocol, body weights, food and water intake were recorded, depression and anxiety-like behaviors as well as learning-memory function was examined. Biochemical analysis including oxidative stress measurement, inflammatory markers and other molecular parameters, critical to behavioral effects were examined. We observed a significant decrease in the body weight in the socially defeated rats as compared to the controls. Furthermore, social defeat increased anxiety-like behavior and caused memory impairment in rats (P<0.05). Socially defeated rats made significantly more errors in long term memory tests (P<0.05) as compared to control rats. Furthermore, brain extracellular signal-regulated kinase-1/2 (ERK1/2), and an inflammatory marker, interleukin (IL)-6 were activated (P<0.05), while the protein levels of glyoxalase (GLO)-1, glutathione reductase (GSR)-1, calcium/calmodulin-dependent protein kinase type (CAMK)-IV, cAMP-response-element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) were significantly less (P<0.05) in the hippocampus, but not in the prefrontal cortex and amygdala of socially defeated rats, when compared to control rats. We suggest that social defeat stress alters ERK1/2, IL-6, GLO1, GSR1, CAMKIV, CREB, and BDNF levels in specific brain areas, leading to oxidative stress-induced anxiety-depression-like behaviors and as well as memory impairment in rats.
    Brain research 10/2013; 1539. DOI:10.1016/j.brainres.2013.09.033 · 2.83 Impact Factor
  • Source
    • "The construct validity of this model lies in part on the fact that amphetamine can worsen symptoms or induce mania relapse in bipolar patients (Salvadore et al., 2010). Moreover, a number of treatments of mania, including mood stabilizers and antipsychotics , have proved effective to reduce the hyperlocomotion triggered by amphetamine, conferring a good predictive validity to this model (Frey et al., 2006b; Wesołowska et al., 2010). We found that a single administration of the PKC inhibitor tamoxifen reduced the hyperlocomotion induced by amphetamine, consistent with the previously reported antimanic-like efficacy of this agent in rats (Einat et al., 2007) or mice (Sabioni et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The neurobiological mechanisms underlying the pathophysiology and therapeutics of bipolar disorder are still unknown. In recent years, protein kinase C (PKC) has emerged as a potential key player in mania. To further investigate the role of this signaling system in mood regulation, we examined the effects of PKC modulators in behavioral tests modeling several facets of bipolar disorder and in adult hippocampal cell proliferation in rats. Our results showed that a single injection of the PKC inhibitors tamoxifen (80 mg/kg, i.p.) or chelerythrine (3 mg/kg, s.c.) attenuated amphetamine-induced hyperlocomotion and decreased risk-taking behavior, supporting the efficacy of PKC blockade in acute mania. Moreover, chronic exposure to tamoxifen (10 mg/kg/day, i.p., for 14 days) or chelerythrine (0.3 mg/kg/day, s.c., for 14 days) caused depressive-like behavior in the forced swim test, and resulted in a reduction of cell proliferation in the dentate gyrus of the hippocampus. Finally, we showed that, contrary to the PKC inhibitors, the PKC activator phorbol 12-myristate 13-acetate (PMA) enhanced risk-taking behavior and induced an antidepressant-like effect. Taken together, these findings support the involvement of PKC in regulating opposite facets of bipolar disorder, and emphasize a major role for PKC in this disease.
    Progress in Neuro-Psychopharmacology and Biological Psychiatry 12/2012; 43. DOI:10.1016/j.pnpbp.2012.11.015 · 4.03 Impact Factor
  • Source
    • "Generally, the abnormal changes of ROS are considered as one of the causal factors in many neurological diseases, such as amnesia (Kwon et al., 2010), Alzheimer's disease (AD) (Nunomura et al., 2010; Strazielle et al., 2009) and other neurodegenerative diseases (Sas et al., 2007). In addition, several studies have shown that moodstabilizing and antipsychotic drugs inhibit oxidative damage and increase the activities of various antioxidant enzymes (Cui et al., 2007; Frey et al., 2006; Shao et al., 2008), suggesting that the process of antioxidative damage may be the target of these drugs. All these evidence "
    [Show abstract] [Hide abstract]
    ABSTRACT: Previous studies reported that melamine could affect hippocampal function and cause spatial cognition impairment. Moreover, some evidences implied that there might be an oxidative damage pathway linking melamine to the function of hippocampus in vitro, but there was a paucity of data about this adverse effect in vivo. The aim of this study was to investigate the toxicology of melamine induced by oxidative damage in hippocampus in vivo. Male Wistar rats were randomly divided into two groups: control group (n=8) and melamine group (n=8). The animals were treated with melamine at a dose of 300 mg/kg/day in 1% carboxymethylcellulose (CMC) solution as a suspension by oral administration, while rats received the same dose of solution of 1% CMC in control group. Melamine was given once a day and for 28 consecutive days. The MWM experiment and histopathological examination were performed. MWM results showed that there were significant deficits of spatial learning and memory in melamine group. The levels of superoxide anion radical, hydroxyl free radical and malonaldehyde (MDA) were significantly increased by melamine, which also reduced the activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px). The analysis of hippocampal energy metabolism showed that melamine caused significant decrease in the content of adenosine-triphosphate (ATP), implying the reduction of energy synthesis in hippocampal neurocytes. The results suggest that the selective neurotoxicity of melamine in hippocampus may be in part associated with oxidative damage.
    Pharmacology Biochemistry and Behavior 04/2012; 102(2):196-202. DOI:10.1016/j.pbb.2012.04.009 · 2.82 Impact Factor
Show more